Jonathan R. Powell
Expertise in
7
conditions

Dr. Jonathan R. Powell

Family Medicine
619 Mount Royal Boulevard, 
Pittsburgh, PA 
On Staff At
Accepting New Patients
Offers Telehealth
Expertise in
7
conditions
619 Mount Royal Boulevard, 
Pittsburgh, PA 

Overview

Jonathan Powell, MD, specializes in family medicine and is certified by the American Board of Family Medicine. He practices at Renaissance Family Practice-UPMC and is affiliated with UPMC St. Margaret. He completed his residency at the University of Pittsburgh School of Medicine.

Dr. Powell is highly rated in 7 conditions, according to our data. His top areas of expertise are Non-Langerhans-Cell Histiocytosis, Multicentric Reticulohistiocytosis, Hemophagocytic Lymphohistiocytosis, and Reticulohistiocytoma.

His clinical research consists of co-authoring 123 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Virginia Medical School

Residency

University of Pittsburgh School of Medicine

Specialties

Family Medicine

Licenses

Family Medicine in PA

Board Certifications

American Board Of Family Medicine

Hospital Affiliations

Magee Womens Hospital Of Upmc Health System
Upmc St Margaret
Upmc Passavant

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 24 Less Insurance Carriers -

Locations

Renaissance Family Practice-UPMC
619 Mount Royal Boulevard, Pittsburgh, PA 15223

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess Its Efficacy, Safety, Impact on Quality of Life, and Long-term Outcome in Pediatric Patients With Primary Hemophagocytic Lymphohistiocytosis
An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess Its Efficacy, Safety, Impact on Quality of Life, and Long-term Outcome in Pediatric Patients With Primary Hemophagocytic Lymphohistiocytosis
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: Emapalumab
Study Phase: Phase 3
A Phase 2/3 Open-label Single Arm Multicentre Study to Assess Safety Tolerability Pharmacokinetics and Efficacy of i.v. Administrations of NI-0501 an Anti-IFNγ mAb in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis
A Phase 2/3 Open-label Single Arm Multicentre Study to Assess Safety Tolerability Pharmacokinetics and Efficacy of i.v. Administrations of NI-0501 an Anti-IFNγ mAb in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: January 13, 2023
Intervention Type: Drug
Study Drugs: Vincristine, Irinotecan, Temozolomide, Metformin
Study Phase: Phase 1
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Pediatric Blood & Marrow Transplant Consortium (PBMTC) Phase II Myeloablative Haploidentical BMT With Post-transplantation Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Pediatric Blood & Marrow Transplant Consortium (PBMTC) Phase II Myeloablative Haploidentical BMT With Post-transplantation Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Enrollment Status: Completed
Publish Date: November 26, 2021
Intervention Type: Radiation, Other, Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

123 Total Publications

Systematic metabolite screening identifies functional regulators of the adenosine A2A receptor.
Systematic metabolite screening identifies functional regulators of the adenosine A2A receptor.
Journal: Communications chemistry
Published: June 18, 2025
Similar Doctors
Richard Zimmerman
Expertise in
6
conditions
Dr. Richard Zimmerman
Family Medicine
Expertise in
6
conditions
Dr. Richard Zimmerman
Family Medicine

Office

6023 Harvard St, 
Pittsburgh, PA 
 (3.9 miles away)
412-661-2802
Languages Spoken:
English
See accepted insurances

Richard Zimmerman is a primary care provider, practicing in Family Medicine in Pittsburgh, Pennsylvania. Dr. Zimmerman is highly rated in 6 conditions, according to our data. His top areas of expertise are Flu, Avian Influenza, Strep Throat, and Tetanus.

Expertise in
11
conditions
Dr. Alisa M. Goldstein
Family Medicine
Expertise in
11
conditions
Dr. Alisa M. Goldstein
Family Medicine
5215 Centre Ave Fl 2, 
Pittsburgh, PA 
 (4.4 miles away)
412-623-2287
Languages Spoken:
English
See accepted insurances

Alisa Goldstein is a primary care provider, practicing in Family Medicine in Pittsburgh, Pennsylvania. Dr. Goldstein is highly rated in 11 conditions, according to our data. Her top areas of expertise are Hirschsprung Disease, Chordoma, Esophageal Cancer, Stomach Cancer, and Parathyroidectomy.

Expertise in
27
conditions
Dr. Richard Cook
Family Medicine
Expertise in
27
conditions
Dr. Richard Cook
Family Medicine

Preferred Primary Care Physicians

104 McClellandtown Rd, 
Uniontown, PA 
 (43.8 miles away)
724-438-1808
Languages Spoken:
English
See accepted insurances

Richard Cook is a primary care provider, practicing in Family Medicine in Uniontown, Pennsylvania. Dr. Cook is highly rated in 27 conditions, according to our data. His top areas of expertise are Psoriatic Arthritis, Psoriasis, Arthritis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Frequently Asked Questions about Dr. Jonathan R. Powell

How do I make an appointment with Dr. Jonathan R. Powell?

You can book an appointment with Dr. Jonathan R. Powell by calling their office at 412-492-3855. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jonathan R. Powell a top-rated expert for Non-Langerhans-Cell Histiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jonathan R. Powell is classified as an Distinguished expert for Non-Langerhans-Cell Histiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jonathan R. Powell specialize in?

While Dr. Jonathan R. Powell is a Family Medicine, they have specific expertise in Non-Langerhans-Cell Histiocytosis, Multicentric Reticulohistiocytosis, and Hemophagocytic Lymphohistiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Jonathan R. Powell participate in research or clinical trials?

Yes. Dr. Jonathan R. Powell has published 123 articles and abstracts on conditions like Non-Langerhans-Cell Histiocytosis. You can view a list of Dr. Jonathan R. Powell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jonathan R. Powell accept my insurance?

Dr. Jonathan R. Powell accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-492-3855 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Powell's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile